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Abstract
Background: Hearing loss prevalence data in South Africa is scarce, especially within primary health care settings. 
Objectives: To determine; (i) the prevalence of  hearing disorders in patients ≥3 years of  age attending two primary health care 
clinics, and (ii) the nature and characteristics of  hearing disorders at these primary health care clinics. 
Method: A cross-sectional design was used at two primary health care clinics. Non-probability purposive sampling was used to 
screen participants at clinics for hearing loss with pure tone audiometry. A total of  1236 participants were screened (mean age 
37.8 ±17.9 years). Diagnostic testing was available for confirmation of  hearing loss on participants who failed the screening. 
Results: Hearing loss prevalence was 17.5% across both clinics. Most hearing losses were bilateral (70.0%) and were of  a sen-
sorineural nature (84.2%). 
Conclusion: Hearing loss prevalence was comparable at both primary health care clinics. Participants 40 years and older were 
at significantly higher risk for hearing loss. The current study is the first attempt to establish hearing loss prevalence for primary 
health care clinics in South Africa.
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Introduction
Hearing loss is a major public health concern affecting 
more than 1.33 billion people globally in 20151. As one of  
the leading contributors to the global burden of  disease, 
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it currently ranks fifth on the global causes of  years lived 
with disability index, higher than other chronic diseases 
such as diabetes or dementia1. A combination of  factors 
is responsible for the upward trend in the global hearing 
loss epidemic. These include increased life expectancy 
leading to the number one cause of  hearing loss, aging. 
The widespread use of  ototoxic treatments for diseases 
such as cancer and tuberculosis, and occupational and 
recreational noise exposure without appropriate protec-
tion are other major contributors to the global burden of  
hearing loss2. 
Hearing loss has a devastating effect on the individual 
with some of  the resulting sequelae including academic 
African 
Health Sciences
© 2018 Louw et al. Licensee African Health Sciences. This is an Open Access article distributed under the terms of  the Creative commons At-
tribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.   
African Health Sciences Vol 18 Issue 2, June, 2018313
failure, higher unemployment, poorer general health, so-
cial isolation and an increased incidence of  depression3,4. 
In addition to its individual effects, hearing loss puts an 
immense financial burden on society. Health care costs, 
excluding rehabilitation services such as hearing devices 
and cochlear implants, are estimated to be in the range of  
US67 -107 billion annually5. The financial burden of  un-
addressed hearing loss, however, is far worse for develop-
ing countries that are challenged by pre-existing poverty, 
environmental risk factors and life-threatening diseases5.
Sub-Saharan Africa is one of  the developing world re-
gions with substantially higher hearing loss prevalence 
compared to developed countries3,6. Available reports 
indicate an estimated prevalence of  11.5 to 20.3% for 
adults (≥ 15 years) and 1.2 to 3.0% for children (5 – 14 
years) in SSA compared to 4.0 to 6.4% (adults ≥ 15 years) 
and 0.3 to 0.6% (children 5 – 14 years) in high-income 
countries6. Hearing loss prevalence in sub-Saharan Afri-
ca may however be underestimated as population-based 
studies are limited7.
Apart from a preliminary population-based study con-
ducted in the Cape Town metropolitan area8, limited 
hearing loss data is available also in South Africa. Similar-
ly hearing loss prevalence in South African communities 
and those attending primary health care (PHC) facilities is 
unknown. It is an important priority to obtain local data 
for hearing loss prevalence at PHC level where commu-
nicable (i.e. tuberculosis) and non-communicable diseases 
(i.e. diabetes), which are associated with acquired hearing 
losses, are being treated9,10. Considering that an estimated 
50% of  the burden of  hearing loss could be prevented11, 
implementing hearing care services such as prevention, 
management and intervention are needed at PHC level. 
Determining the prevalence of  hearing loss is required 
for adequate health planning to increase access to hearing 
care services within communities. This study describes 
the prevalence and nature of  hearing loss of  those at-
tending two South African PHC clinics.
 
Materials and methods
This research project was approved by the Institutional 
Research Board of  the University of  Pretoria, South Af-
rica and was part of  a larger community oriented primary 
care (COPC) project in Gauteng province in the City of  
Tshwane12.
Selection and description of  participants
A cross-sectional design was used at two PHC clinics 
(PHC clinic 1 and PHC clinic 2) situated in different 
underserved communities in Tshwane. Non-probability 
purposive sampling was used to screen participants as it 
was a clinical, non-experimental set-up and results would 
therefore be representative of  the clinic population. At 
PHC clinic 1, universal screening took place by offering 
all individuals who visited the clinic a hearing screening 
free of  charge. At PHC clinic 2, all individuals who were 
available during the time that the services were delivered 
and who wanted their hearing tested were screened free 
of  charge. Only individuals visiting the clinic as patients 
were selected as participants. Diagnostic testing was avail-
able for confirmation of  hearing loss on participants who 
failed the screening. Participants aged three years and old-
er were included in the study. This criterion was includ-
ed as the preferred method of  testing children younger 
than 3 years of  age is visual response audiometry (VRA) 
which was not available at the clinics. Only participants 
who provided signed consent (children had to provide 
assent along with a signed consent letter from their par-
ent/caregiver) and who completed the screening protocol 
(i.e. completed a re-screen upon referral of  initial screen) 
were included in the study. Instructions were provided 
in English or Afrikaans. Written instructions in Sepedi 
were used if  participants did not understand English or 
Afrikaans. If  participants were unable to understand one 
of  these three languages, a health care nurse who was 
available at the specific time, was asked to translate the 
information. Participants who presented with a mixed 
or conductive hearing loss were referred to the clinics’ 
general practitioner for further medical examination and 
intervention. Participants who presented with a sensori-
neural hearing loss (SNHL) were referred to the nearest 




Hearing screening was facilitated by undergraduate au-
diology students from the University of  Pretoria under 
supervision of  an experienced audiologist (first author). 
Otoscopy was performed with a handheld Welch Allyn 
otoscope (Welch Allyn, South Africa) as a pre-screen to 
determine any obvious abnormalities of  the external ear 
canal or tympanic membrane. Any obvious abnormali-
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ties of  the external ear canal or tympanic membrane 
were noted. Testing was conducted in an examination 
room without sound isolation. Due to time and facility 
constraints at clinics more than one participant was ex-
amined at the same time in a room in some instances. 
In these instances, more than one student audiologist 
was available to evaluate participants. Smartphone hear-
ing screening was performed using two sets of  Samsung 
Galaxy Pocket Plus S5301 phones running the validated 
hearScreen™ Android OS application with calibrated su-
pra-aural Sennheiser HD202 II headphones (Sennheiser, 
Wedemark, Germany)13,14. The application’s integrated 
real-time monitoring of  ambient noise levels provided a 
measure of  quality control13. Screening audiometry was 
conducted, according to recommended guidelines15 using 
a 1, 2 and 4 kHz sweep with screening levels of  25 dB HL 
or 35 dB HL for participants younger than 15 years and 
15 years and older respectively13. These age cut-offs are 
in line with the World Health Organization16. Immediate-
ly following a fail result, the participant was re-screened. 
Only those who failed both screenings were considered 
to have failed the hearing screening test. Findings from 
previous studies indicate that hearScreen™ can be used 
as a reliable screening tool, also in PHC settings13,17. To 
determine screening specificity in this particular study, di-
agnostic testing was performed on a group of  111 partic-
ipants who passed the screening. 
 
Diagnostic testing
To determine the prevalence and nature of  hearing loss, 
pure tone audiometry was performed on the same day on 
participants who failed the screening for a second con-
secutive time. Automated pure tone audiometry (air- and 
bone conduction) was performed at 0.5, 1, 2, 4 kHz us-
ing a Type 2 Clinical Audiometer (KUDUwave, eMoyo, 
South Africa). Insert earphones were placed deep in 
the ear canal with circumaural headphones placed over 
the ears to improve attenuation of  ambient noise, and 
to minimize the occlusion effect. An automated thresh-
old-seeking paradigm was utilized with a similar thresh-
old-seeking method used in manual test configuration i.e. 
the modified Hughson-Westlake method. Air and bone 
conduction thresholds were determined with masking 
of  the non-test ear when indicated. The software active-
ly monitored ambient noise levels across octave bands 
throughout the test procedures in both clinics. Whenever 
the noise exceeded the maximum ambient noise level al-
lowed for establishing a threshold, the test operator wait-
ed for the transient noise to subside.
 
Data analysis
Diagnostic testing confirming a hearing loss informed 
the prevalence rate for this population. The presence of  
a hearing loss was defined as a pure tone threshold aver-
age (0.5, 1, 2 or 4 kHz) greater than 25 dB HL in one or 
both ears18. A hearing loss was classified as conductive 
when the average difference between the pure tone air 
conduction and bone conduction thresholds (0.5 kHz – 4 
kHz) was 15 dB HL or greater with normal air conduc-
tion thresholds18. A hearing loss was classified as a sen-
sorineural hearing loss (SNHL) when the pure tone air 
and bone conduction thresholds (0.5 kHz – 4 kHz) were 
abnormal (> 25 dB HL) with an average air-bone gap less 
than 15 dB HL. The classification of  a mixed hearing loss 
(conductive and sensorineural) entailed abnormal air and 
bone conduction thresholds with an average air-bone gap 
of  15 dB HL or greater. Another hearing loss category 
(“other”) was added in the current study to include par-
ticipants with different types of  hearing losses in the two 
ears i.e. a SNHL and conductive hearing loss. The degree 
of  the hearing loss was classified as mild (> 25 dB HL and 
≤ 40 dB HL), moderate (> 40 dB HL and ≤ 55 dB HL), 
moderate to severe (> 55 dB HL and ≤ 70 dB HL) and 
severe to profound (> 70 dB HL)18. A unilateral hearing 
loss was obtained when one ear had normal hearing with 
a hearing loss in the other ear. A bilateral hearing loss 
indicated a hearing loss present in both ears. Data analy-
sis was performed using SPSS v23 (Armonk, New York). 
Demographic data, screening and diagnostic results were 
analysed and presented using descriptive statistics. A one 
way ANOVA analysis was performed to evaluate the ef-
fect of  age, gender and race on the presence of  a hearing 




A total of  1236 participants were included in the study 
(PHC 1: n=633; PHC: n=603) (Table 1). The mean age 
was 37.8 years (±17.9 years, range 3 – 97 years). Twenty 
six participants (22 adults, four children) at PHC clinic 1 
and two participants (2 adults) at PHC clinic 2 were ex-
cluded from the study because the screening protocol was 
not completed due to operator error. Two other partici-
pants were omitted from the study group at PHC clinic 
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2 because their date of  birth was not captured. Two hun-
dred and sixteen (17.5%) participants failed the hearing 
screening (PHC 1 = 18.8%, PHC 2 = 16.1%). 4.8% par-
ticipants failed in the 3-14 years category, whilst 10.5% 
and 25.4% failed in the 15 – 39 years and > 40 years cat-
egories respectively. Of  the 216 participants who failed, 
138 participants were tested diagnostically whilst 78 did 
not attend the diagnostic assessment.













  White 35.6% (440) - 73.0% (440) 
Gender       
Male 28.7% (355) 25.3% (160) 32.3% (195) 
Female 71.3% (881) 74.7% (473) 67.7% (408) 
Age       
3 – 14 years 







≥40 years 44.3% (548) 43.1% (278) 44.7% (270) 
 
One hundred and twenty (9.7%) of  the participants (mean 
age 49.8±19.8 years) presented with a confirmed hearing 
loss (PHC 1=9.3%; PHC 2=10.1%) (Table 2). When the 
78 participants who failed the screening, but who did not 
attend for diagnostic testing, are included, the prevalence 
is 17.5% across both clinics. The majority of  persons with 
hearing loss presented with a bilateral loss (70.0%,n=84). 
SNHL (uni- and bilateral) was the most common type 
of  hearing loss (84.2%, n=101) followed by conductive 
(3.3%, n=4) and mixed hearing loss (1.7%, n=2). Sixty 
seven adults and two children presented with a bilateral 
sensorineural hearing loss (Table 2). 
Table 2. Nature of hearing loss in adults and children (n=120) 
 





SNHL Other (SNHL & mixed, 
SNHL & conductive, 
conductive & mixed) 
≥ 15 years 1.7% (2) 1.7% (2) 81.0% (97) 9.2% (11) 
3-14 years 
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Thirteen participants (10.8%) were diagnosed with com-
binations of  SNHL, conductive or mixed losses in re-
spective ears (Table 3). Nineteen participants (9 partici-
pants with conductive hearing loss, 10 participants with 
mixed hearing loss) were referred for further medical in-
vestigation. The majority of  the hearing impaired (38.0%) 
participants presented with a moderate degree of  hearing 
loss (Table 4). Race and gender did not have a significant 
effect on hearing loss (p>.05; ANOVA) but age had a sig-
nificant effect (p< .05) with hearing sensitivity decreasing 
by 3.4 dB (95% CI: 0.25 – 0.45) for every additional year.
Table 3. Prevalence and nature of hearing loss (n=120) 
 
  Total (n=1236) PHC 1 (n=633) PHC 2 (n=603) 
All 
3-14 years 
  15 – 39 years 














SNHL 2.6% (32) 3.8.% (24) 1.3% (8) 
Conductive 0.2% (2) 0.2% (1) 0.2% (1) 
Mixed 0.2% (2) - 0.3% (2) 
Bilateral       
SNHL 5.6% (69) 4.1% (26) 7.1% (43) 
Conductive 0.2% (2) 0.3% (2) - 
Mixed - - - 
Other       
SNHL & Mixed 0.6% (7) 0.3% (2) 0.8% (5) 
SNHL & Conductive 0.4% (5) 0.6% (4) 0.1% (1) 




Table 4. Degree of hearing loss (based on the worst 
ear pure tone average) (n=120) 
 
Degree Total (n=120) PHC 1 (n=59) PHC 2 (n=61) 
Mild 29.2% (35) 32.2% (19) 26.2% (16) 
Moderate 38.0% (45) 31.0% (18) 44.2% (27) 
Moderate to severe 11.7% (14) 8.5% (5) 14.8.% (9) 
Severe to profound 21.7% (26) 28.8% (17) 14.8% (9) 
 
Discussion
Hearing loss prevalence data in Africa varies greatly. The 
current study revealed a hearing loss prevalence of  17.5% 
at two PHC clinics in underserved communities in the 
Tshwane area. This is slightly higher than the 12.35% 
prevalence reported in the Cape Town metropolitan area8 
whilst it is very similar to an estimated range of  11.4% - 
20.3% for sub-Saharan Africa6. Different contexts such 
as school settings or population-based contribute to the 
prevalence variation. The current study investigated hear-
ing loss prevalence at PHC clinics. Different hearing test 
techniques employed also contribute to the variation. 
Also, in studies where pure tone audiometry was used as 
the screening method, there was also a wide variation in 
the intensity cut-off  criteria i.e. 25 dB HL, 30 dB HL, 35 
dB HL7. Using a stricter screen intensity such as 25 dB 
HL will identify milder hearing losses, and will produce 
a higher prevalence whilst a pure tone cut off  at 40 dB 
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HL will result in a lower prevalence as only moderate and 
severe losses will be included. The cut off  criteria in the 
current study was of  25 dB HL (children) and 35 dB HL 
(adults). These intensities were selected to identify dis-
abling hearing loss in children (>30 dB HL) and adults 
(>40 dB HL)16; however there may have been a small per-
centage of  adults with slight hearing loss (> 25 dB < 35 
dB) that may have passed the hearing screening.
There is an upward trend in hearing loss prevalence with 
increasing age18. The age differences in age groups also 
contribute to the prevalence discrepancy in Africa. Of  
the hearing loss participants was a significant factor in the 
current study with 15.0% of  the participants 40 years or 
older presenting with a hearing loss Cruickshanks et al.18, 
showed that the risk of  hearing loss, specifically SNHL 
increased by almost 90% for every five years of  age. In 
the US, approximately two thirds of  adults age 70 years 
and older present with a hearing loss18,19. 
In the same age group in Europe at least 30% of  men 
and 20% of  women are affected by a hearing loss20. Only 
limited age-related prevalence evidence is available for 
sub-Saharan Africa. A study conducted in Nigeria indi-
cated 6.1% of  people aged 65 years and older self-report-
ed hearing impairment21. Self-report of  hearing loss is a 
quick and inexpensive way to determine hearing handi-
cap, though the use of  it in prevalence studies is limited if  
not validated against pure tone audiometry as the severity 
and site of  lesion cannot be determined22,23. Two recent 
community based studies conducted in PHC settings also 
in the Tshwane area showed that increasing age had an 
impact on audiometric screening referral rate24,17. Both 
studies indicated that 25% of  adults older than 40 years17 
and 45 years24 were at risk hearing loss. In the current 
study, SNHL was the most common type of  hearing loss 
observed among the hearing impaired participants who 
attended the diagnostic follow-up (n=120). Uni- and bi-
lateral SNHL was observed in 2.6% and 5.6% of  the
participants respectively with 1.0% of  the participants 
presenting with a bilateral loss which is sensorineural in 
nature in at least one ear. Conductive hearing loss, which
refers to a middle ear pathology resulting in a loss of  au-
dibility, was observed in 0.2% of  the hearing impaired 
participants with 0.5% of  the hearing impaired present-
ing with a bilateral hearing loss which is conductive in 
nature in at least one ear. 
A recent systematic review demonstrated that middle ear 
disease, that could ultimately lead to conductive hearing 
loss, is the most common cause not only in the school-
aged population, but also in the general population7. The 
screening cut off  criteria was not aimed to identify mild 
conductive hearing losses, hence the low prevalence in 
the current study.
 
With the great variation in hearing loss prevalence due 
to different contexts, screening techniques and different 
age groups, it is imperative to recognize the lack of  pop-
ulation-based studies in Africa. Hearing loss is a signifi-
cant public concern being a highly prevalent and chronic 
condition. Individuals and communities are challenged 
by a variety of  adverse effects as well as high costs. The 
negative effects and expenses in communities could be 
alleviated by implementing hearing care at PHC level. 
Implementing ear and hearing services at PHC level will 
require careful planning and identification of  specific 
program goals and specification of  care pathways. The 
current study is the first attempt in establishing hearing 
loss prevalence baselines and descriptions at PHC clin-
ics. Novel hearing detection solutions, capitalizing on ad-
vances in technology and connectivity, which were used 
in the current study, provide the possibility to expand and 
decentralize hearing care services to PHC level.
Study limitations
A limitation of  the study was that participants younger 
than three years of  age were not included. Furthermore, 
the population was sampled purposively and not random-
ly taking into consideration power and precision. This 
was mainly due to the clinical time and human resource 
constraints of  the research setting.
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